Literature DB >> 8778545

Role of exercise in the evaluation and management of pulmonary disease in children and youth.

P A Nixon1.   

Abstract

Asthma is the most common chronic pulmonary disorder affecting children in the U.S. Cystic fibrosis is the most common life-shortening inherited disease affecting white populations. With both disorders, children may have impaired exercise tolerance and abnormal cardiopulmonary responses to exercise. Exercise testing can aid in the diagnosis of exercise-induced asthma, and in determining prognosis in cystic fibrosis. Children with asthma and cystic fibrosis have been shown to benefit from exercise training, mainly through improved aerobic fitness and cardiopulmonary efficiency. In summary, exercise plays a valuable role in the evaluation and management of children with asthma and cystic fibrosis.

Entities:  

Mesh:

Year:  1996        PMID: 8778545     DOI: 10.1097/00005768-199604000-00004

Source DB:  PubMed          Journal:  Med Sci Sports Exerc        ISSN: 0195-9131            Impact factor:   5.411


  5 in total

1.  Exercise testing in children with cystic fibrosis.

Authors:  Diane Rogers; S Ammani Prasad; Iolo Doull
Journal:  J R Soc Med       Date:  2003       Impact factor: 5.344

2.  High-sweat Na+ in cystic fibrosis and healthy individuals does not diminish thirst during exercise in the heat.

Authors:  M B Brown; N A McCarty; M Millard-Stafford
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2011-08-03       Impact factor: 3.619

Review 3.  Exercise recommendations for individuals with cystic fibrosis.

Authors:  S R Boas
Journal:  Sports Med       Date:  1997-07       Impact factor: 11.136

4.  Exercise performance and quality of life in children with cystic fibrosis and mildly impaired lung function: relation with antibiotic treatments and hospitalization.

Authors:  Kristof Vandekerckhove; Michiel Keyzer; Jasper Cornette; Ilse Coomans; Filip Pyl; Frans De Baets; Petra Schelstraete; Filomeen Haerynck; Daniel De Wolf; Sabine Van Daele; Jan Boone
Journal:  Eur J Pediatr       Date:  2017-09-30       Impact factor: 3.183

5.  Sildenafil improves exercise capacity in patients with cystic fibrosis: a proof-of-concept clinical trial.

Authors:  Paula Rodriguez-Miguelez; Haruki Ishii; Nichole Seigler; Reva Crandall; Jeffrey Thomas; Caralee Forseen; Kathleen T McKie; Ryan A Harris
Journal:  Ther Adv Chronic Dis       Date:  2019-11-21       Impact factor: 5.091

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.